Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 120.04%61.1K | -137.65%-165.14K | 82.75%-176.61K | 0.88%-1.01M | -135.13%-124.75K | 76.01%-304.83K | 438.63K | -844.16%-1.02M | -64.71%-1.02M | 610.62%355.09K |
| Net income from continuing operations | 82.11%-51.62K | -83.09%87.9K | 97.68%-34.99K | -153.19%-3.83M | -792.98%-2.55M | 73.64%-288.58K | --519.87K | -1,051.27%-1.51M | -114.44%-1.51M | 11.98%-285.13K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---130K | -103,900.00%-130K | ---90 |
| Depreciation and amortization | --0 | -30.28%6.29K | -117.97%-46 | 7,317.97%18.99K | 1,838.67%4.96K | --4.75K | --9.02K | --256 | --256 | --256 |
| Asset impairment expenditure | ---- | ---- | ---- | --2.25M | ---- | ---- | ---- | ---- | --0 | ---- |
| Unrealized gains and losses of investment securities | --0 | --0 | -383.02%-3.75K | -5.66%1.25K | 0.00%-1.25K | -51.46%1.25K | ---75 | --1.33K | -97.87%1.33K | -113.48%-1.25K |
| Remuneration paid in stock | --0 | --0 | --0 | -58.04%275.99K | --0 | --0 | ---381.83K | --657.82K | 252.44%657.82K | --657.82K |
| Change In working capital | 739.67%142.32K | -260.43%-259.32K | -225.49%-137.82K | 724.81%264.56K | 1,114.32%167.51K | 54.24%-22.25K | --161.64K | -285.75%-42.34K | 74.47%-42.34K | -128.25%-16.51K |
| -Change in receivables | 1,008.42%128.36K | -737.93%-109.95K | 285.64%3.88K | 867.64%16.04K | 229.92%15.02K | -244.29%-14.13K | --17.24K | -548.76%-2.09K | 65.83%-2.09K | -445.54%-11.56K |
| -Change in prepaid assets | -131.09%-3.4K | -141.23%-5.51K | 115.74%3.43K | 131.04%6.75K | 125.57%4.24K | 217.07%10.92K | --13.35K | -622.85%-21.76K | -128.22%-21.76K | -166.84%-16.6K |
| -Change in payables and accrued expense | 190.39%17.21K | -209.60%-143.63K | -466.19%-104.7K | 1,188.82%201.35K | 826.13%107.82K | 61.22%-19.04K | --131.06K | -197.56%-18.49K | 87.69%-18.49K | -67.44%11.64K |
| -Change in other working capital | --147 | ---235 | ---40.42K | --40.42K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 120.04%61.1K | -137.65%-165.14K | 82.75%-176.61K | 0.88%-1.01M | -135.13%-124.75K | 76.01%-304.83K | --438.63K | -844.16%-1.02M | -64.71%-1.02M | 610.62%355.09K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 65.86%-52.07K | -99.99%33 | 96.46%-22.15K | 26.41%-460.1K | 78.36%-60.72K | 45.12%-152.5K | 378.38K | -835.63%-625.26K | -243.39%-625.26K | -120.13%-280.56K |
| Capital expenditure reported | 65.82%-52.07K | --0 | 96.51%-22.11K | 28.17%-455.57K | 78.33%-60.79K | 46.89%-152.36K | --391.81K | -849.08%-634.24K | -248.09%-634.24K | -120.13%-280.56K |
| Net PPE purchase and sale | --0 | 100.74%33 | ---33 | ---4.53K | --62 | ---149 | ---4.44K | --0 | --0 | --0 |
| Net business purchase and sale | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --588 | --588 | --0 |
| Net investment purchase and sale | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --8.4K | 6,620.00%8.4K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 65.86%-52.07K | -99.99%33 | 96.46%-22.15K | 26.41%-460.1K | 78.36%-60.72K | 45.12%-152.5K | --378.38K | -835.63%-625.26K | -243.39%-625.26K | -120.13%-280.56K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 99.46%-7.62K | -100.00%56 | -101.27%-17.92K | -100.34%-4.79K | -4.5K | -1.42M | 1.42M | -52.65%1.42M | -35.64%1.42M |
| Net issuance payments of debt | --0 | 11.67%-7.62K | --56 | ---17.92K | ---4.79K | ---4.5K | ---8.63K | --0 | --0 | --0 |
| Net common stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --1.42M | -52.65%1.42M | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 99.46%-7.62K | -100.00%56 | -101.27%-17.92K | -100.34%-4.79K | ---4.5K | ---1.42M | --1.42M | -52.65%1.42M | -35.64%1.42M |
| Net cash flow | ||||||||||
| Beginning cash position | -86.99%165.84K | -81.28%389.35K | -74.73%577.76K | -9.03%2.08M | -32.10%832.68K | -38.98%1.28M | -0.44%2.08M | 0.00%2.29M | 3,370.76%2.29M | 392.00%1.23M |
| Current changes in cash | 101.95%9.03K | 71.53%-172.73K | 15.15%-198.7K | -537.54%-1.49M | -125.50%-190.27K | 42.64%-461.83K | ---606.7K | -33.60%-234.18K | -110.72%-234.18K | -62.72%746.24K |
| Effect of exchange rate changes | 174.89%53.19K | -735.41%-50.78K | -62.94%10.28K | -134.49%-9.57K | -160.05%-64.65K | 133.33%19.35K | --7.99K | 226.91%27.74K | -22.52%27.74K | 200.69%107.66K |
| End cash Position | -72.61%228.06K | -86.99%165.84K | -81.28%389.35K | -72.23%577.76K | -72.23%577.76K | -32.10%832.68K | -38.98%1.28M | -0.44%2.08M | -9.03%2.08M | -9.03%2.08M |
| Free cash from | 101.97%9.03K | -119.99%-165.11K | 88.01%-198.75K | 11.05%-1.48M | -348.86%-185.48K | 70.64%-457.33K | --825.99K | -846.03%-1.66M | -106.27%-1.66M | 137.83%74.53K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.